Bozeman Deaconess Cancer Center
Bozeman, Montana, United States
Cancer treatment center in Bozeman, Montana
931 Highland Blvd #3130, Bozeman, MT 59715
About Bozeman Deaconess Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
57
SWOG Cancer Research Network
53
National Cancer Institute (NCI)
26
ECOG-ACRIN Cancer Research Group
7
NSABP Foundation Inc
7
Eastern Cooperative Oncology Group
5
Radiation Therapy Oncology Group
2
ETOP IBCSG Partners Foundation
1
M.D. Anderson Cancer Center
1
North Central Cancer Treatment Group
1
University of South Florida
1
Clinical Trials at Bozeman Deaconess Cancer Center
During the past decade, Bozeman Deaconess Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 92 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
2002-04-01
Terminated
265
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2002-04-01
2014-02-01
Completed
58
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
2002-12-01
Completed
171
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Bozeman Deaconess Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 57 trials, followed by "SWOG Cancer Research Network" with 53 trials
sponsored, "National Cancer Institute (NCI)" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NSABP Foundation Inc"
with 7 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bozeman Deaconess Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 135 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Bozeman Deaconess Cancer Center
According to Clinical.Site data, the most researched conditions in "Bozeman Deaconess Cancer Center" are
"Breast Cancer" (30 trials), "Lung Cancer" (19 trials), "Lymphoma" (16 trials), "Leukemia" (11 trials) and "Prostate Cancer" (10 trials). Many other conditions were trialed in "Bozeman Deaconess Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Bozeman Deaconess Cancer Center
Most popular intervention types in "Bozeman Deaconess Cancer Center" are "Drug" (128 trials), "Other" (55 trials), "Biological" (51 trials), "Radiation" (23 trials) and "Procedure" (19 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (26 trials), "cyclophosphamide" (17 trials), "bevacizumab" (15 trials), "rituximab" (12 trials) and "radiation therapy" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Bozeman Deaconess Cancer Center
The vast majority of trials in "Bozeman Deaconess Cancer Center" are
128 trials for "All" genders, 23 trials for "Female" genders and 11 trials for "Male" genders.
Clinical Trials Status at Bozeman Deaconess Cancer Center
Currently, there are NaN active trials in "Bozeman Deaconess Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 123 completed trials in Bozeman Deaconess Cancer Center,
undefined suspended trials,
and 23 terminated clinical trials to date.
Out of the total trials that were conducted in Bozeman Deaconess Cancer Center, 6 "Phase 1"
clinical trials were conducted, 86 "Phase 2" clinical
trials and 58 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".